GGT8P

Across TCGA pan-cancer cohorts, GGT8P Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated GGT8P data layer compared with 23 for mass-spec protein.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher GGT8P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated GGT8P expression acts as an unfavorable survival marker.

OV, CESC, and COAD are the cancer types where GGT8P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Median	II,III,IV	0.053	0.846	<.001	36	view →
CESC	OS	Median	All	0.167	0.798	<.001	30	view →
COAD	OS	Median	All	0.001	0.871	<.001	21	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

GGT8P–OV (OS)

Open the OV breakdown →